Why us

9001:2015
Why us
Technology
The use of Synthetic Nanotechnologies for high-throughput screening allows us to create a new generation of fast and efficient test systems for molecular diagnostic markets.
Synthetic Oligonucleotides
OxGEn Synthetic primer sequences are modified to improve their stability, sensitivity, and characteristics, making them highly adaptable to different diagnostic applications. Furthermore, the utilization of AI algorithms is resulting in sequences, that cab be better tailored for specific diagnostic applications

Oligo-Coated Magnetic Nanoparticles for Selective Purification of Polynucleotides 

OxMag offers a synthetic oligonucleotide-coated silica/iron nanoparticle-based method for the selective isolation of nucleic acids. The use of synthetic nanoparticles with a magnetic core and an outer layer of oligonucleotides presents several advantages in the purification of DNA and RNA. The oligonucleotides on the surface of the particles can be designed to selectively bind to target molecules, making these particles applicable in a range of diagnostic applications.

Patent: AC536621, “Patent Application,” submitted January 23, 2023, Georgian Office.

Certified
The company is ISO 9001-2015 certified and several product lines are CE-IVDR-registered. The production facility of 300 square meters is located in Natakhtari, Georgia, where BSL2 laboratories are equipped with all the necessary instruments to undertake cutting-edge research and Analytical and clinical tests.

Grants and Awards

GITA Georgian Innovation and Technology Agency and World Bank.

Project: Production of Molecular Biology Reagents.

We envision a future where high-throughput screening processes are not only fast and efficient but also capable of delivering accurate and actionable results. We aim to create a new generation of test systems that will make it easier for medical professionals to diagnose and treat a variety of conditions.

We believe that by combining cutting-edge nanotechnology with modern synthetic oligo synthesis, can generate actionable results for high-throughput screenings. 

We are dedicated to continuing our research and development in this field, and to constantly pushing the boundaries of what is possible with synthetic nanotechnologies. We are committed to working closely with our partners in the medical and scientific communities to ensure that our technology is used to its full potential, and to make a positive impact on the lives of patients everywhere. 

Innovation: We believe in constantly pushing the boundaries of what is possible in disease diagnostics, leading to new and improved solutions.

Collaboration: We believe in working closely with healthcare providers,  to better understand their needs and co-create solutions that meet those needs.

Accessibility: We are dedicated to making our solutions accessible to everyone, regardless of location, income, or healthcare infrastructure.

Integrity: We hold ourselves to the highest standards of ethical and scientific integrity, ensuring that our products and practices are always driven by a commitment to improving outcomes.

Quality: We are committed to delivering high-quality products and services that meet or exceed industry standards, ensuring that our customers can rely on us to provide accurate and reliable results.

OxGEn's production facilities are situated in the Natakhtari region, located approximately 20 kilometers from Tbilisi, Georgia. The company operates state-of-the-art facilities covering an area of 300 square meters and comprising both Production and BSL2 Laboratories
At our company, we take pride in our state-of-the-art production facility, which is equipped with all the technologies needed to meet industry standards and deliver high-quality products.
At our company, we pride ourselves on our research and development (R&D) department's commitment to innovation and exploration. Our team is always ready and willing to take on new ideas and challenges, especially when it comes to working with complex and challenging molecules.
Previous slide
Next slide
OxGEn's production facilities are situated in the Natakhtari region, located approximately 20 kilometers from Tbilisi, Georgia. The company operates state-of-the-art facilities covering an area of 300 square meters and comprising both Production and BSL2 Laboratories
At our company, we take pride in our state-of-the-art production facility, which is equipped with all the technologies needed to meet industry standards and deliver high-quality products.
At our company, we pride ourselves on our research and development (R&D) department's commitment to innovation and exploration. Our team is always ready and willing to take on new ideas and challenges, especially when it comes to working with complex and challenging molecules.
Previous slide
Next slide
Partners